RET fusions occur in ∼10% of papillary thyroid carcinomas (PTC), 1%–2% of non-small cell lung cancers (NSCLC), and rarely in other malignancies (Addeo et al., 2023). The gene discussed is RET; the disease is non-small cell lung carcinoma.